Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials Article

publication date

  • October 1, 2021

webpage

published in

keywords

  • IL-13
  • IL-4
  • chronic rhinosinusitis with nasal polyps
  • dupilumab
  • non-steroidal anti-inflammatory drug-exacerbated respiratory disease